Expert Interviews

Bladder-Sparing Innovations in MIBC: Dr. Elizabeth Plimack on the RETAIN Approach and Its Future
Dr. Elizabeth Plimack, MD, MS, FASCO, is a Professor of Medical Oncology and the Deputy Director of Fox Chase Cancer Center. A recognized leader in the treatment of genitourinary malignancies, Dr. Plimack’s work primarily focuses on bladder and kidney cancers. At Fox Chase Cancer Center, Dr. Plimack and her team have pioneered an innovative approach to bladder preservation in patients with muscle-invasive bladder cancer (MIBC). Through clinical trials like RETAIN-1 and RETAIN-2, they are challenging traditional treatment paradigms by exploring systemic therapy-based strategies as alternatives to radical ...
Advertisement
Advertisement

Featured Knowledge Hubs

Prostate Cancer
Prostate Cancer
Advertisement
Advertisement